Liver biopsy: Archaic but resilient and many roads lead to Rome
- PMID: 38952693
- PMCID: PMC11216678
- DOI: 10.1097/CLD.0000000000000247
Liver biopsy: Archaic but resilient and many roads lead to Rome
Conflict of interest statement
K. Rajender Reddy advises and received grants from Mallinckrodt. He advises Spark Therapeutics, Pfizer, Novo Nordisk, and R2R Pharma. He received grants from BMS, Intercept, Exact Sciences, GSK, Camarus, Grifols, Sequana, HCC-TARGET, and NASH-TARGET. He is on the data safety monitoring board for Genkyotex, HiTide, Novartis, and Astra Zeneca.
Figures




References
-
- Frerichs FT. U¨ eber den Diabetes. A. Hirschwald; 1884:272.
-
- Sherlock S. Aspiration liver biopsy—Technique and diagnostic application. Lancet. 1945;2:397–401.
-
- Dible J, Michael J, Sherlock S. Pathology of acute hepatitis. Lancet. 1943;ii:402–403.
-
- Sharma OP. The Life of Sheila Sherlock, ‘The Liver Queen ’ Royal College of Physicians London; 2007.
-
- Sherlock S. Disease of the Liver and Biliary System Vol. 3. Blackwell Scientific Publications; 1955:69–81.
Publication types
LinkOut - more resources
Full Text Sources